Smoking cessation is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive and can cause dependence. Nicotine withdrawal often makes the process of quitting difficult.
Clinical Research Consortium is to look at a drug called cytisinicline to see how effective it is at enabling people to quit smoking as compared to a placebo, which is an inactive substance. The study will last approximately 24 weeks with 19 visits to our office and one phone call. Dosing will be an oral medication, taken 3 times per day.
- Duration: Up to 7 months.
- Number of visits: 19 plus 1 phone-call visit
- Compensation: $100 per completed visit.
Qualified Participants are:
- Age 18 years or older
- Smoking at least 10 cigarettes/day
- Failed to quit smoking at least once
- Motivated to quit
- Willing to quit 5-7 days after starting the study
- Willing to adhere to the time and compliance requirements
Qualified Participants will Recieve:
- Study-related care at no cost
- Highest standards of care overseen by a licensed Physician
- Compensation for time and travel
- Insurance is not required
Fill out the form on the right-hand side of the page and see if you qualify for our clinical trial →